Synthetic Biologics, Inc.
STABILIZED PERTUSSIS ANTIBODIES WITH EXTENDED HALF-LIFE
Last updated:
Abstract:
The present invention relates, in part, to modified humanized antibodies which bind the pertussis toxin protein and their use as therapeutic agents. In particular, the present invention is directed, in part, to improved humanized 1B7 and 11E6 antibodies with extended in vivo half-lives.
Status:
Application
Type:
Utility
Filling date:
15 Aug 2017
Issue date:
28 Oct 2021